LevitasBio looks forward to meeting you at Cincinnati Children's Hospital's 12th Annual Imaging and Cytometry Research Day! Stop by our table, or attend our talk to learn more about our novel cell enrichment technology and to find out if LeviCell is better than FACS... Location: S1.203/4 Time: 12:00 - 12:15 pm, lunch box provided Presentation: […]
LevitasBio looks forward to meeting you at Johns Hopkin's 2nd Annual Single Cell Symposium on September 29-30, 2022 in the Turner Concourse. Attend our company showcase to learn how our novel cell enrichment technology elevates your single cell work by: Uncovering native scRNA-seq transcriptomic signatures Enriching the highest quality cells and robust scRNA data Enabling […]
Empower Your Immuno-oncology Research With Targeted Enrichment of Specific Immune Cell Markers LevitasBio is excited to attend this year’s Society for Immunotherapy of Cancer Annual Meeting, held November 8-12, 2022 in Boston, MA. Our team members, Melissa Ma and Camila Egidio, will be on-site, and ready to discuss your cellular analysis needs. Request a meeting to learn […]
On Sunday, Dec 4th, join our poster presentation to learn how to minimize isolation-induced inflammatory response signaling in immune cells.
Extensive manipulation, mechanical force, and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is identification of drug targets that are not relevant to the biological process under study. Based on Nakhoda and Olszanski, 2022 (Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies), lack of an optimal biomarker is one of the main challenges to clinical trial success. This represents a huge loss for both industry and the advance of medicine.
On Wednesday, December 14, 2022 from 11am to 1pm, our team will be on hand at Bio-EV's Genomics Showcase Fair to introduce you to the world of levitation. Stop by to learn how we levitate cells, and the benefits this novel technology offers over traditional cell sorting and isolation methods you may be using today. Meet […]
Cell and Gene therapy provides great promise to treat many diseases, such as B-cell malignancies, with FDA-approved CAR-T cells. Immune cells are first isolated from the patient or donor, followed by activation, expansion, and ex vivo genetic modification of selected immune cells. It is important to control and monitor the quantity and quality of immune cells throughout the development process as well as in the final product release phase as recommended by the Chemistry, Manufacturing, and Control (CMC) FDA guidelines.
In this webinar, Dr. Kevin Travers, from LevitasBio. Inc. will present a novel technology and optimized workflows to enrich primary cells from various challenging samples without damaging fragile cells.
Our 2nd speaker, Dr. Leo Chan, from Nexcelom Bioscience will describe optimized real-time apoptosis assays for 2D or 3D in vitro cell culture samples performed on the Cellaca® PLX and Celigo high-throughput cell counting and image cytometry systems.
Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions in the future of Next Generation Sequencing, Multi-omic Single Cell & Spatial Analyses and Genome editing in Drug Discovery and Therapeutic Development.
In recent years, single-cell RNA sequencing has transformed our understanding of cellular heterogeneity within highly complex tissues and organs, revealing thus far undiscovered cell types and states and characterizing perturbations in disease. However, despite the advances in single-cell technologies, not all tissues and samples can be successfully profiled. This is often due to poor sample quality or low cell viability that can arise due to harsh tissue processing and cell isolation methods. Often, these are precious clinical samples.
In this webinar, Dr. Kevin Travers, from LevitasBio. Inc. will present a novel technology and optimized workflows to enrich primary cells from various challenging samples without damaging fragile cells.
Our 2nd speaker, Dr. Leo Chan, from Nexcelom Bioscience will describe optimized real-time apoptosis assays for 2D or 3D in vitro cell culture samples performed on the Cellaca® PLX and Celigo high-throughput cell counting and image cytometry systems.
The LevitasBio team is proud to announce there will be two posters highlighting the advanced LeviCell system at the AACR Annual Meeting 2023, April 14 – 19, in Orlando, Florida.
The ABRF Annual Meeting is an international program that provides timely updates on cutting-edge science and its execution in a shared resource/core facility setting. The meeting offers informative and practical workshops and ample networking opportunities with academics, corporate, and technology partner colleagues. Join our Senior VP of Research & Development, Kevin Travers, Ph.D., at […]
CYTO 2023, the Congress for the International Society for the Advancement of Cytometry is a premier, inclusive, and international conference on the many facets of cytometry science and engineering. Join us this year in Montréal, Québec. CYTO 2023 will explore how cytometry has flourished in the past decade and will showcase exciting discoveries for the future.
